Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Stemhagen, Annette
NCT01511393: An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)	Enrolling by invitation	N/A	6750	US	No treatment given	Novo Nordisk A/S, AstraZeneca, Eli Lilly and Company, United BioSource, LLC	Diabetes, Diabetes Mellitus, Type 2, Medullary Thyroid Carcinoma, Weight Management	12/39	12/39
Contact
METAL-2, NCT06505239: Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication	Completed	N/A	26	US	FSD-F2R6-A-CP, Placebo	Quantum Biopharma	Acute Alcohol Intoxication	11/24	11/24